Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01942135
Brief Title: Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

First Submitted : September 10, 2013
First Submitted that Met QC Criteria : September 10, 2013
First Posted : September 13, 2013 (Estimate)

Results First Submitted : December 3, 2015
Results First Submitted that Met QC Criteria : April 15, 2016
Results First Posted : May 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 26, 2021
Last Update Posted : July 28, 2021